Cytokinetics, Inc. (CYTK)
60.75
+0.44
(+0.72%)
USD |
NASDAQ |
Dec 11, 16:00
60.75
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics Free Cash Flow: -453.38M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Jasper Therapeutics, Inc. | -76.53M |
| Lantheus Holdings, Inc. | 411.69M |
| Bristol Myers Squibb Co. | 15.30B |
| Pfizer Inc. | 10.38B |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -107.50M |
| Cash from Investing (Quarterly) | -70.98M |
| Cash from Financing (Quarterly) | 330.47M |
| Free Cash Flow Per Share (Quarterly) | -0.974 |
| Free Cash Flow to Equity (Quarterly) | -455.65M |
| Free Cash Flow to Firm (Quarterly) | -90.54M |
| Free Cash Flow Yield | -6.27% |